Results 191 to 200 of about 84,160 (241)
Some of the next articles are maybe not open access.

Arylsulfonamide CB2 Receptor Agonists: SAR and Optimization of CB2 Selectivity

Bioorganic and Medicinal Chemistry Letters, 2008
A high-throughput screening campaign resulted in the discovery of a highly potent dual cannabinoid receptor 1 (CB1) and 2 (CB2) agonist. Following a thorough SAR exploration, a series of selective CB2 full agonists were identified.
Brian W Dymock   +2 more
exaly   +3 more sources

Cannabinoid CB1 and CB2 Receptor Ligand Specificity and the Development of CB2-Selective Agonists

Current Medicinal Chemistry, 2008
Cannabinoids in current use such as nabilone activate both CB1 and CB2 receptors. Selective CB2 activation may provide some of the therapeutic effects of cannabinoids, such as their immuno-modulatory properties, without the psychoactive effects of CB1 activation.
John C Ashton, Joel D. A. Tyndall
exaly   +3 more sources

Targeting the Cannabinoid CB2 Receptor: Mutations, Modeling and Development of CB2 Selective Ligands

Current Medicinal Chemistry, 2005
Since the discovery of the cannabinoid CB2 receptor in 1993, there has been a growing interest to clarify the importance of this G-protein coupled receptor (GPCR) for human physiology, and to investigate it as a possible target for current and future drug development.
K H, Raitio   +4 more
openaire   +2 more sources

NMR Characterization of Recombinant Transmembrane Protein CB2 Fragment CB2 180-233

Protein & Peptide Letters, 2006
The expression of membrane proteins has been the bottleneck for their structural studies. Recently, we developed a method to obtain milligram quantities of isotope-labeled seven transmembrane G-protein coupled cannabinoid (CB) receptor fragment in E. coli.
J, Zhao, H, Zheng, X-Q, Xie
openaire   +2 more sources

CB2 Receptor Ligands

Mini-Reviews in Medicinal Chemistry, 2005
The CB(1) receptor is found principally in the central nervous system and is responsible for the overt physiological effects of cannabinoids. In contrast, the CB(2) receptor is expressed primarily in the immune system and is responsible for few, if any, obvious behavioral effects.
openaire   +2 more sources

Imidazopyridine CB2 agonists: Optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacy

Bioorganic & Medicinal Chemistry Letters, 2011
A new series of imidazopyridine CB2 agonists is described. Structural optimization improved CB2/CB1 selectivity in this series and conferred physical properties that facilitated high in vivo exposure, both centrally and peripherally. Administration of a highly selective CB2 agonist in a rat model of analgesia was ineffective despite substantial CNS ...
B Wesley, Trotter   +19 more
openaire   +2 more sources

Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands

Current Medicinal Chemistry, 2013
Cannabinoids have potential therapeutic value e.g. in pain relief, cancer therapy, control of nausea and vomiting, and appetite stimulation, but their therapeutic benefits are limited by unwanted central nervous system (CNS) side-effects. Separating the therapeutic effects of cannabinoid agonists from their undesired CNS effects can be achieved by ...
openaire   +3 more sources

To CB2 or not CB2: Revisiting renoprotection in acute and chronic kidney injury

British Journal of Pharmacology
Abstract The cannabinoid receptor 2 (CB2), which is encoded by the Cnr2 gene, is a G‐protein‐coupled receptor that controls immune responses and has recently emerged as a regulator of renal injury and repair.
Jonathan M. de Jesus   +2 more
openaire   +2 more sources

To CB2 or Not CB2: Revisiting Renoprotection in AKI and CKD

Cannabinoid receptor 2 (CBS) is a G-protein coupled receptor that controls immune responses and has recently emerged as a regulators of renal injury and repair. Over the past 15 years, numerous pharmacological and genetics studies have explored the role of CB2 in acute kidney injury (AKI) and chronic kidney disease (CKD). Using a wide array of chemical,
Jonathan de Jesus, Bob Moore, Frank Park
openaire   +1 more source

Home - About - Disclaimer - Privacy